Vol. 48, No. 1, 1972
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
GANGLIOSIDEBIOSYNTHESISIN MOUSECELLS: GLYCOSYLTRANSFERASE ACTIVITIES IN NORMALANDVIRALLY-TRANSFORMED LINES Peter H. Fishman*, Vivian W. McFarlandt; Peter T. Morat, and Roscoe 0. Brady* *National Institute of Neurological Disease and Stroke and tNationa1 Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014 Received
May 22,
1972
of four glycosyltransferases involved in ganglioSummary- The activities side biosynthesis were measured in two different established mousecell lines and in the SV40 and polyoma transformed variants of these lines. The only consistent change observed was the very reduced activity of UDP-GalNAc: hematoside N-acetyl-galactosaminyltransferase in all of the transformed cell lines (15-20% of normal cells). There was no significant differences in any of the glycosyltransferases with increased cell density and cell-to-cell contact. Cells in culture growth properties changes (3-5). lipid
transformed by oncogenic DNAviruses have altered
(1) loss of contact inhibition Several laboratories
and glycoprotein
(2) and cell surface
have reported differences
compositions in such transformants
Studies with established mousecells
indicate
in glyco-
(6-9).
a less complex ganglioside
composition in SV40 and polyoma transformed lines.
Whereas the major
GM1' and GDla' generally the virally-transformed cells have mainly GM3 (6,10-12). The absence of these higher gangliosides are GM3’ ,
GM2’
gangliosides appears to be due to a decrease in the enzyme UDP-N-Acetylgalactosamine:
hematoside N-acetylgalactosaminyltransferase
Since the biosynthesis
(13,14).
of gangliosides appears to proceed by the
sequential addition of monosaccharide units from sugar nucleotide
1 The abbreviations used are: AcNeu, N-acetyl-neuraminic acid; cer, ceramide (N-acylsphingosine). For glycosphingolipids containing sialic acid the symbols proposed by Svennerholm (17) are used. G NAc, N-acetylneuraminylgalactosylglucosylceramide (hematoside); GM2, z3 acetylgalactosaminyl-[N-acetylneuraminyl]-galactosylglucosylcer~ide; galactosyl-N-acetylgalactosaminyl-[N-acetylneuraminyl]-galactosyliy&;osylceramide; G N-acetylneuraminyl-galactosyl-N-acetylgalactosaminyl-[N-acetylneur~~~yl]-galactosylglucosylceramide.
Copyright All rights
0 19 72 by Academic Press, Inc. in any form reserved.
of reproduction
48
Vol. 48, No. 1, 1972
BIOCHEMICAL
FIGURE
1.
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
BIOSYNTIIETIC
PATHWAY
Lactosylceramide
FOR GANGLIOSIDES
Cer-glc-
gal
CMP-AcNeu
1
Sialyltransferase
I
CMP cer-glc-gal
‘M3
A!Neu
UDP-CalNAc 2
N-acetylgalactosaminyltransferase
UDP 4 cer-glc-gal-galNAc I AcNeu
GM2 UDP-Cal
3
Galactosyltransferase
UDP
G
cer-glc-gifl-galNAc-gal Ml
CMP-AcNeu 4
Sialyltransferase
II
CMP cer-glc-gal-galh’Ac-gal G
Dla
AC t.!eu
donors to the elongating glycolipid biosynthetic
acceptor (Fig. l),
enzymes are presumed to exist
it was important to determine if viral decrease in one specific thetic
pathway is altered.
AcNeu ’
(lS),
and the
as a multi-enzyme complex (15,16),
transformation
glycosyltransferase
results in a
or whether the entire biosyn-
The present communication compares the levels of
these enzymes in normal and virally-transformed
cells.
EXPERIMENTAL PROCEDURE Cells and cell culture:
The various established mousecell lines and
conditions used in these experiments have been described previously
(6,14).
The normal (N-AL/N) and transformed (SVS-AL/N and PY-AL/N) are non-clonal cell
lines while the three Swiss 3T3 cell
49
lines (normal Swiss 3T3 and
Vol. 48, No. 1, 1972
BIDCHEMICAL
transformed SVlOl and PYll) just prior
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
are clonal derivatives.
Cells were harvested
to confluency unless otherwise noted.
Preparation of cell homogenates: The cells were harvested as previously described (14).
The washed packed cells were suspended in nine volumes of
0.25 M sucrose containing thawing four
0.1% 2-mercaptoethanol and disrupted by freeze-
in a dry ice-ethanol
times
bath.
Enzymatic activities
obtained with this procedure were comparable to those obtained with the previous technique of rupturing Glycolipid
acceptors and sugar nucleotide
dog erythrocytes
and further
from the brain of a patient gift
cells by sudden decompression (13)2.
purified
donors:
GM3NAcwas prepared from
and analyzed (13).
GM2was prepared
with Tay-Sachs disease (18) and was a generous
from Dr. Andrew Gal, NINDS. GM1was prepared from bovine brain ganglio-
sides (19).
Lactosylceramide was obtained from Miles Laboratories.
nucleotides were purchased from the following g-galactosamine (14 UDP-galactose-l-
mCi
sources:
per mmole) from International
Sugar
UDP-N-Acetyl-l- 14cChemical and Nuclear;
14C (254 mCi per mmole) and CMP-N-acetylneuraminic acid14 C] (223 mCi per mmole) from New England Nuclear;
[sialic-4,5,6,7,8,9-
UDP-galactose from Sigma (used to dilute
UDP-galactose- 14C to 4 mCi per
mmole). Enzyme Assays:
The reaction
various glycosyltransferase incubation,
mixtures and incubation
conditions
assays are described in Table 1.
for the
After
the reactions were terminated by adding 20 volumes of chloro-
form-methanol (2:l v/v) (60:30:4.5 v/v/v)
(CM) and 40 volumes of chloroform-methanol-water
(CMW). These mixtures were passed through 1 x 2.5
colums of Sephadex G-25 superfine
(lg) previously
equilibrated
cm
with CMW.
The columns were then washed with 5 ml of CMW(4 ml for N-acetylgalactosaminyl-transferase radioactive
assays).
glycolipid
This procedure effectively
products from the radioactive
separates the
sugar nucleotide
precursors (13). The eluants were dried and the radioactivity 2 Unpublished observations of P. H. Fishman and R. W. Smith.
50
determined
donor
50 )11
for
Glycosyltransferase
50 !.I1
CF-54 50 ug Tween - - 20 ul
2x10' cpm UDP-Gal 5 umoles pH 7.2 100 ug Triton
10 nmoles GM2
80
Assays
50 u1
- - 20 lJ1
50 pg Tween
10' cpm CMP-AcNeu 5 umoles pH 6.5 100 ug Triton
GM1
50 nmoles
Sialyltra sferase II a
a) Assay conditions same as ref. 20; 16; d) Assay conditions same as ref. b) Assay 21.
conditions
similar
to ref.
13; c) Assay
conditions
80
same as ref.
Glycolipid acceptors were added to the reaction tubes in CM and taken to dryness. The remaining components were then added and the reactions initiated by addition of the cell homogenates (4-6 mg protein per ml) followed by vigorous swirling. After incubating at 37OC for 2 hrs. the reactions were terminated by adding 1 ml CM and 2 ml CMW. The radioactive ganglioside products there then isolated as described under "EXPERIMENTAL PROCEDURE."
50 ?ll
- - 10 ?ll
x-100
cutscum
50 nmoles GM3NAc 10' cpm UDP-GalNAc 2.5 umoles pH 7.2 200 ug Triton
Final
volume
Conditions
Glycosyltransferase N-acetylgalactos-b Galactosylaminyltransferase transferaseC
and Incubation
10' cpm CMP-AcNeu 5 umoles pH 6.35 750 vg
50 nmoles cer-glc-gal
100 1J.g 20 ul
(14C)
acceptor
Cardiolipin Cell homogenate
Na Cacodylate buffer Detergents
Sugar
Glycolipid
Component
Mixtures
Sialyltrans ferase Ia
Reaction
TABLE I
CF-54
z F r z
?I
F 6 5
g 2 F
Vol. 48, No. 1, 1972
by liquid activity
BIOCHEMICAL
scintillation
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Each determination of enzyme
spectrometry.
represents net incorporation
of radioactive
acceptor and was calculated by subtracting incorporation
sugar onto exogenous
endogenous incorporation
from
with added acceptor. RESULTSANDDISCUSSION
Factors influencing conditions
enzyme activities:
of linearity
acceptor concentrations activation
in terms of
Each enzyme assay was run under and protein
time
were saturating
or inhibition
for all
assays.
Sialyltransferase
lines was stimulated 3-7 fold by cardiolipin.
had been reported for this sameenzyme activity (BHK) cells
(20).
No
Glycolipid significant
was observed when homogenates from normal and
transformed lines were assayed together. the cell
content.
Cardiolipin
I in all of
Similar findings
in baby hamster kidney
at 100 ug per incubation mixture produced
maximumactivity. Effect
of Cell Density on Glycosyltransferase
been reported that quantity
of certain
cell contact in somecontact-inhibited
Activities:
glycolipids cell
Since it has
increase upon cell-to-
lines
(22, 23), the influence
of cell density on the ganglioside biosynthesizing
enzymes was investigated.
Swiss 3T3 cells were plated in inocula of 5 x 104, lo', cells per plate.
The cells were harvested after
5 x lo5 and lo6
3 days by gentle trypsini-
zation in order to obtain suspensions for cell counting. procedure had no effect ferases exhibited
on the transferase
a slight
activitiesA.
decrease in specific
increased whereas the other two transferases
The trypsinization Both sialytrans-
activity
fluctuated
as cell density slightly
(Fig. 2).
For comparative purposes, cells were routinely
harvested at preconfluency
while still
Similar experiments with
in a logarithmic
clonal derivatives
phase of growth.
of Balb 3T3 cells
indicated
changes in N-acetylgalactosominyltransferase These cell lines were:
that there were no substantial activity
with cell density
OA31, a normal Balb 3T3; SO-IIA41 and llA8,
transformed Balb 3T3; and 10 A 7, a "flat
52
revertant"
(24).
SV40
SV40 transformed Balb
Vol. 48, No 1,1972
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
.
SIALYLTRANSFERASE
A
N-ACETYLGALACTOSAMINYL-
A
GALACTOSYLTRANSFERASE
0
SIALYLTRANSFERASE
I
TRANSFERASE
SPARSE
SUBCONFLUENT
CELL
CONFLUENT
DENSITY
AT
FIGURE
Effect
II
POSTCONFLUENT
HARVEST
2
of cell density on glycosyltransferases.
Swiss 3T3 cells were
plated in inocula of 5x104, 105, 5X105, and lo6 cells per plate. cells were harvested after determined. confluent,
three days and the number of cells were
Cell densities
(cells per cm2) were:
3x104, confluent,
1~10~; post-confluent,
syltransferase
activities
PROCEDURE."The activities
concentrations
(22, 23, 26).
in confluent
mousecells,
in hamster cells
cells.
reported to occur in hamster cells
it recently
(27).
in culture
were not determined in
correlated
Whether these different
53
changes
has been reported that cell
density dependent changes in glycosyltransferases glycolipids
Glyco-
to the cell density-dependant
Although ganglioside concentrations
sparse and confluent
1.5~10~.
of each transferase have been normalized
The results are in contrast
in glycolipid
sparse, 1~10~; sub-
were determined as described under "EXPERIMENTAL
and are given as the percent activity
3T3 (25).
The
with changes in observations
Vol. 48, No. 1, 1972
BIOCHEMICAL
are due to differences class of glycolipid
in cell
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
type, or in clones (cf.
has yet to be determined.
ent changes in glycolipid
concentrations
ref.
26, 28), or in
However, cell density-depend-
does not appear to be a general
phenomenon. Enzyme levels in normal and transformed cells: glycosyltransferases of Swiss 3T3 cells
in normal and virally-transformed are given in Table II.
galactosaminyltransferase.
experi-
viral
transformation
in
lines was the marked decrease in N-acetylThe altered
uncloned and cloned virally-transformed laboratory
of similar
lines are presented in Table III.
change in enzyme levels after
both Swiss 3T3 and AL/N cell
clonal derivatives
The results
ments with the various non-clonal AL/N cell The only consistant
Levels of the ganglioside
ganglioside composition of both cell
lines investigated
is in agreement with this observation
(6, 10, 11).
in this Sialtrans-
ferase I is reduced in a polyoma transformed BHKclonal cell
line (20) and
was reported to be lower in SV40 transformed Swiss 3T3 (29).
This enzyme
activity
was elevated in SVlOl and PY AL/N, unaffected
moderately diminished in SVS AL/N.
Sialytransferase
decreased in SV40 transformed Swiss 3T3 cells normal was found by us in the SVlOl cells.
,in PYll and II was reported to be
(29); lower activity
However, this enzyme activity
was higher in both PY AL/N and SVS AL/N than in the control The results after
suggest that the alteration
transformation
effects results,
N AL/N cell line.
in ganglioside biosynthesis
of established mousecells by oncogenic DNAviruses
are complex when considering the change in activities glycosyltransferases.
than
of the various
SV40 and polyoma appear to induce somewhatdifferent
and the host cell may influence
any virally
mediated changes.
The
however, continue to support a commonbiochemical change in SV40
and polyoma virus-transformed N-acetylgalactosaminyltransferase.
mousecells;
reduced activity
Whether this consistantly
54
of a specific observed
Vol. 48, No. 1, 1972
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
55
Vol. 48, No. 1, 1972
BIOCHEMICAL
AND BIOPHYSICAL
56
RESEARCH COMMUNICATIONS
Vol. 48, No. 1, 1972
change is directly
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
related to viral
transformation
quence of selection during the transformation
or a secondary conse-
process remains to be
determined and cloning experiments are underway to explore these alternatives.
REFERENCES 1. 2.
3. 4. 5. 6. 7. a. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29.
22: 391 (1968). Black, P. H., Ann. Rev. Microbial., Abercrombie. M.. Eur. J. Cancer. 6: F(1970). Burger, M.M: and Goldberg, A.D.; Froc. Natl: Acad. Sci., -57: 359 (1967). Tevethia, S.S., Katz, M. and Rapp, F., Proc. Sot. Exp. Biol. Med., 119: 896 (1965). Hakomori, S., Teather, C. and Andrews, H., Biochem. Biophysic. Res. commun., 33: 563 (1968). Mora, P.T., Brady, R.O., Bradley, R.M. and McFarland, V.W. Proc. Natl. Acad. Sci., 63: 1290 (1969). Hakomori, S. and Murxami, W.T., Proc. Natl. Acad. Sci., -59: 254 (1969). Wu, H.C., Meezan, E., Black, P.H. and Robbins, P.W., Biochem., 8: 2509 (1969). Buck, C.A., Glick, M.C. and Warren, L., Biochem., 9: 4567 (1970). Brady, R.O. and Mora, P.T., Biochem. Biophysic. Acta., 218: 308 (1970). Dijong, I., Mora, P.T. and Brady, R.O., Biochem., 10: 4039 (1971). Sheinen, R., Onodera, K., Yogeeswaran, G., and Murray, R.K., The Biology of Oncogenic Viruses, IInd Le Petit Symposium, Milan Le Petit, p. 274 (1970). Cumar, F.A., Brady, R.O., Kolodny, E.H., McFarland, V.W. and Mora, P.T., Proc. Natl. Acad. Sci., 67: 757 (1970). Mora, P.T., Cumar, F.A. and Brady, R.O., Virology, 46: 60 (1971). Roseman,S., Chem. Phys. Lipids, 2: 270 (1970). Cumar, F.A., Fishman, P.H. and Brady, R.O., J. Biol. Chem., 246: 5075 (1971). Svennerholm, L., J. Neurochem., 10: 613 (1963). Gatt, S. and Berman, E.R., J. Neurochem., 10: 43 (1963). Kolodny, E.H., Brady, R.O., Quirk, J.M. anrKanfer, J.N., J. Lipid Research, 11: 144 (1970). Den, H., Schztz, A.M., Basu, M. and Roseman,S., J. Biol. Chem. 246: 2721 (1971). Kasan, B., Basu, S., and Roseman,S., J. Biol. Chem., 243: 5804 (1968). Hakomori, S., Eroc. Natl. Acad. Sci., 67: 1741 (1970). Robbins, P.W., and McPherson, I.A., PrG. Roy. Sot., -177: 49 (1971); also Nature, -229: 569 (1971). Cumar, F., and Mora, P.T., Unpublished observations. Smith, H.S., Scher, C.D. and Todaro, G.J., Virology, 44: 359 (1971). Sakiyama, H., Gross, S.K. and Robbins, P.W., Proc. Nax. Acad. Sci., 69: 872 (1972). Kijmoto, S. and Hakomori, S., Biochem. Biophysic. Res. Commun.,-44:557 (1971). Yogeeswaran, G., Schimmer, B.P., Sheinin, R., and Murray, R.K., Fed. Proc., &, 438 Abs. Grimes, W.J., Sasaki, T., and Robbins, P.W., Fed. Proc., E:, 1185 Abs. (1971).
57